Fny Investment Advisers, LLC Merck & Co., Inc. Transaction History

Fny Investment Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $1.9 Million - $2.04 Million	15,350 Added 214.69%	22,500 $2.79 Million
Q1 2024 May 02, 2024	BUY	$113.24 - $131.95 $809,666 - $943,442	7,150 New	7,150 $943,000
Q4 2018 Jan 22, 2019	SELL	$65.24 - $75.71 $97,859 - $113,564	-1,500 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$57.69 - $67.84 $86,535 - $101,760	1,500 New	1,500 $106,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.